Clinical Trials Browser

Phase 2 × Basal Cell Nevus Syndrome × gusacitinib × Clear all

NCT04416516 2024-04-10

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell